Evidence of 'amplifier effect' in pulmonary multidrug-resistant tuberculosis: report of three cases

International Journal of Infectious Diseases

Volumn 11, Issue 6, 2007, Pages 508-512

  Umubyeyi, A ^a,b   Shamputa, I C ^a,c   Rigouts, L ^a   Dediste, A ^b   Struelens, M ^d   Portaels, F ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^c TROPICAL DISEASES RESEARCH CENTRE   (Zambia)

^d ERASME HOSPITAL   (Belgium)

Author keywords

Amplifier effect; Multidrug resistant tuberculosis (MDR TB); Mycobacterium tuberculosis; Spoligotyping, MIRU VNTR

Indexed keywords

CIPROFLOXACIN; CLOFAZIMINE; ETHAMBUTOL; ISONIAZID; OFLOXACIN; PROTIONAMIDE; PYRAZINAMIDE; QUINOLONE DERIVATIVE; RIFAMPICIN; STREPTOMYCIN;

ADOLESCENT; ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; DNA EXTRACTION; DRUG DOSE REGIMEN; DRUG SENSITIVITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; MALE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS;

ADOLESCENT; ADULT; ANTITUBERCULAR AGENTS; CLUSTER ANALYSIS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; MYCOBACTERIUM TUBERCULOSIS; SIBLINGS; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 35449002914     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2007.01.009     Document Type: Article

References (31)

1. Braden C.R., Morlock G.P., Woodley C.L., Johnson K.R., Colombel A.C., Cave M.D., et al. Simultaneous infection with multiple strains of Mycobacterium tuberculosis. Clin Infect Dis 33 (2001) 42-47
2. Fernando C., Fernando D., Mercedes A.S., and Noriega Antonio R. Evidence of exogenous reinfection and mixed infection with more than one strain of Mycobacterium tuberculosis among Spanish HIV-infected inmates. AIDS 13 (1999) 615-620
3. Rich M.L. The PIH guide to the medical management of multidrug-resistant tuberculosis. International Edition (2003), Partners in Health, USA
4. Kanduma E., McHugh T.D., and Gillespie S.H. Molecular methods for Mycobacterium tuberculosis strain typing: a user's guide. J Appl Microbiol 94 (2003) 781-791
5. Shamputa I.C., Rigouts L., Eyongeta L.A., El Aila N.A., van Deun A., Salim A.H., et al. Genotypic and phenotypic heterogeneity among Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients. J Clin Microbiol 12 (2004) 5528-5536
6. Torrea G., Levee G., Grimont P., Martin C., Chanteau S., and Gicquel B. Chromosomal DNA fingerprinting analysis using the insertion sequence and the repetitive element DR as strain-specific markers for epidemiological study of tuberculosis in French Polynesia. J Clin Microbiol 33 (1995) 1899-1904
7. Genewein A., Telenti A., Bernasconi C., Mordasini C., Weiss S., Maurer A.M., et al. Molecular approach to identifying route transmission of tuberculosis in the community. Lancet 342 (1993) 841-844
8. Mazars E., Lesjean S., Banuls A.L., Gilbert M., Vincent V., Gicquel B., et al. High-resolution minisatellite-based typing as a portable approach to global analysis of Mycobacterium tuberculosis molecular epidemiology. Proc Natl Acad Sci USA 98 (2001) 1901-1906
9. Thierry D., Brisson N.A., Levy-Frébault V.V., Nguyen S., Guesdon J.L., and Gicquel B. Characterization of Mycobacterium tuberculosis insertion sequence IS6110, and its application in diagnosis. J Clin Microbiol 28 (1990) 2668-2673
10. Kamerbeek J., Schouls L., Kolk A., van Agterveld M., van Soolingen D., Kuijper S., et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 35 (1997) 907-914
11. McAdam R.A., Hermans P.W., Van Soolingen D., Zainuddin Z.F., Catty D., van Embden J.D., et al. Characterization of a Mycobacterium tuberculosis insertion sequence belonging to the IS3 family. Mol Microbiol 4 (1990) 1607-1613
12. Supply P., Mazars E., Lesjean S., Vincent V., Gicquel B., and Locht C. Variable human minisatellite-like regions in the Mycobacterium tuberculosis genome. Mol Microbiol 36 (2000) 762-771
13. Kwara A., Schiro R., Cowan L.S., Hyslop N.E., Wiser M.F., Roahen Harrison S., et al. Evaluation of the epidemiologic utility of secondary methods for differentiation of Mycobacterium tuberculosis isolates. J Clin Microbiol 41 (2003) 2683-2685
14. Barlow R.E., Gascoyne-Binzi D.M., Gillespie S.H., Dickens A., Shanan Q., and Hawkey P.M. Comparison of VNTR and IS6110-RFLP analysis for discrimination of high and low copy number IS6110 Mycobacterium tuberculosis isolates. J Clin Microbiol 39 (2001) 2453-2457
15. Allix C., Supply P., and Fauville-Dufaux M. Utility of fast mycobacterial interspersed repetitive unit-variable number tandem repeat genotyping in clinical mycobacteriological analysis. Clin Infect Dis 39 (2004) 783-789
16. Dellagi D.C., Abderahman A., Haltiti R., Koubaji H., Gicquel B., and Dellagi K. Large scale DNA fingerprinting of Mycobacterium tuberculosis strains as a tool for epidemiological studies of tuberculosis. J Clin Microbiol 31 (1993) 2446-2450
17. Cowan L.S., Mosher L., Diem L., Massey J.P., and Crawford J.T. Variable-number tandem repeat typing of Mycobacterium tuberculosis isolates with low copy numbers of IS6110 by using mycobacterial interspersed repetitive units. J Clin Microbiol 40 (2002) 1592-1602
18. Bastian I., and Portaels F. Multidrug-resistant tuberculosis (2000), Kluwer Academic Publishers, The Netherlands
19. Farmer P., and Kim J.Y. Community based approach to the control of multidrug resistant tuberculosis: introducing 'DOTS-plus'. Br Med J 317 (1998) 671-676
20. Kleeberg HH, Koornhof HF, Palmhert H. Laboratory manual of tuberculosis methods. Second Ed. Revised by Nell E, Kleeberg HH, Gatner EMS. Pretoria, South Africa: Tuberculosis Research Institute; 1980.
21. Pfyffer G.E., Bonato D.A., Ebrahimzadeh A., Gross W., Hotaling J., Kornblum J., et al. Multicenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media. J Clin Microbiol 37 (1999) 3179-3186
22. Power D.A., and McCuen P.J. Manual of BBL products and laboratory procedure. Sixth ed. (1998), Becton Dickinson, USA
23. Siddiqi S.H. BACTEC 460 TB systems. Product and procedure manual (1996), Becton Dickinson, USA
24. Hewlett Jr. D., Horn D.L., and Alfalla C. Drug-resistant tuberculosis: inconsistent results of pyrazinamide susceptibility testing. JAMA 273 (1995) 916-917
25. Cutler R.R., Wilson P., Villarroel J., and Clarke F.V. Evaluating current methods for determination of the susceptibility of mycobacteria to pyrazinamide, conventional, radiometric Bactec and two methods of pyrazinamidase testing. Lett Appl Microbiol 24 (1997) 127-132
26. Heifets L.B. Antituberculosis drugs: antimicrobial activity in vitro. In: Heifets L.B. (Ed). Drug susceptibility in the chemotherapy of mycobacterial infections (1991), CRC Press, Boca Raton, FL, USA p. 40-1, 80, 164-5
27. Inderlied C.B., and Salfinger M. Antimicrobial agents and susceptibility tests. In: Murray P.R., Baron E.J., Pfaller M.A., Tenover F.C., and Yolken R.H. (Eds). Manual of clinical microbiology. Seventh ed. (1999), American Society for Microbiology, Washington D.C., USA 1606-1623
28. Bulatovic V.M., Wengenack N.L., Uhl J.R., Hall L., Roberts G.D., Cockerill III F.R., et al. Oxidative stress increases susceptibility of Mycobacterium tuberculosis to isoniazid. Antimicrob Agents Chemother 46 (2002) 2765-2771
29. Farmer P.E., Shin S.S., Bayona J., Kim J.Y., Furin J.J., and Brenner J.G. Making DOTS-Plus work. In: Bastian I., and Portaels F. (Eds). Multidrug-resistant tuberculosis (2000), Kluwer Academic Publishers, Dordrecht, The Netherlands 285-306
30. World Health Organization. Antituberculosis drug resistance in the world. Third Global Report. Geneva, Switzerland: World Health Organization; 2004.
31. Quy H.T., Lan N.T., Borgdoff M.W., Grosset J., Linh P.D., Tung L.B., et al. Drug resistance among failure and relapse cases of tuberculosis: is the standard re-treatment regimen adequate?. Int J Tuberc Lung Dis 7 (2003) 631-636